Paying users zone. Data is hidden behind: .
Get 1-month access to Regeneron Pharmaceuticals Inc. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Selected Financial Data
since 2005
Beginner level
Income Statement
Regeneron Pharmaceuticals Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenues | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Balance Sheet: Assets
Regeneron Pharmaceuticals Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Balance Sheet: Liabilities and Stockholders’ Equity
Regeneron Pharmaceuticals Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2019 | ||||
| Dec 31, 2018 | ||||
| Dec 31, 2017 | ||||
| Dec 31, 2016 | ||||
| Dec 31, 2015 | ||||
| Dec 31, 2014 | ||||
| Dec 31, 2013 | ||||
| Dec 31, 2012 | ||||
| Dec 31, 2011 | ||||
| Dec 31, 2010 | ||||
| Dec 31, 2009 | ||||
| Dec 31, 2008 | ||||
| Dec 31, 2007 | ||||
| Dec 31, 2006 | ||||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Cash Flow Statement
Regeneron Pharmaceuticals Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Per Share Data
Regeneron Pharmaceuticals Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
1, 2, 3 Data adjusted for splits and stock dividends.